Table 1

Examples of host and environmental variables influencing the diagnostic workup in patients assessed for suspected DILI

FactorAlternative diagnosisDiagnostic appraisal
Age
<40 yearsWilson's diseaseCeruloplasmin, copper in 24-hour urine, ABCB7 genetic testing
>60 years (DILI is most often cholestatic regardless of the drug)Benign and malignant biliary obstructionMRI and/or ERCP
If inconclusive and damage persists, consider liver biopsy
Type of injury
Cholestatic/mixedBenign and malignant biliary obstructionMRI and/or ERCP
If inconclusive and damage persists, consider liver biopsy
Comorbidities
1. Cardiovascular disease (right/congestive heart failure, coronary artery disease)Ischaemic hepatitisTowering AST/ALT
Search for prior hypotensive episodes
Echocardiogram
2. Hyperthyroidism (untreated)Thyrotoxic hepatitisT3, T4, TSH
3. Type 1 diabetes mellitus (poorly controlled)Glycogenic hepatopathyConsider liver biopsy
4. Pre-existing liver disease (AIH, ALD, NASH, HBV, HCV)Flare-up of underlying liver diseaseConsider liver biopsy
Subject behaviour and local burden of infectious diseases
1. Sexual transmissionSyphilisSerology for acute infection
2. Tropical and developing areas (±underlying HIV infection)Malaria, dengue, tuberculosis, typhoid fever, leptospirosis and othersSpecific serology
3. Hepatitis E (exposure to farm animals, consumption of undercooked pork)Differential diagnosis in acute hepatitis suspected to be DILI39Specific serology (anti-HEV IgM and IgG, HEV PCR)
  • ALD, alcoholic liver disease; AIH, autoimmune hepatitis; ALT, alanine aminotransferase; AST, aspartate aminotransferase; DILI, drug-induced liver injury; ERCP, endoscopic retrograde cholangio-pancreatography; HEV, hepatitis E virus; NASH, nonalcoholic steatohepatitis; TSH, thyroid-stimulating hormone.